Skip to the main content.

Enteric Hyperoxaluria

PHASE 1A/B

Case Studies

Here you can edit the background of the section

Key Takeaways

The client was struggling to enroll a clinical trial evaluating an investigational therapy for enteric hyperoxaluria in patients who had previously undergone Roux-en-Y bariatric surgery — a common cause of the condition. This was the first in-human study for the investigational therapy.

Patients are not often aware they have enteric hyperoxaluria and don’t know it is associated with painful and recurring kidney stones. So, then, how do you interest and enroll patients in a clinical trial?

Drawing on in-depth research and prior experience recruiting patients with kidney stones, BBK Worldwide leveraged a bold strategy that prioritized the very real aspect of kidney stones. BBK made the connection between bariatric surgery and kidney stones clear for patients, creating awareness and interest in the study.

CASE-STUDY__Enteric-Hyperoxaluria_Image2

CASE-STUDY__Enteric-Hyperoxaluria_Image3

 

Challenges 


Many patients are not aware of enteric hyperoxaluria and its relationship to bariatric surgery and kidney stones.

Because levels of oxalate in the kidneys fluctuate, many patients may initially prequalify for the study, only to fail the in-depth screening hours later.

 

 

 

Solutions and Impact

BBK cast a large net by targeting patients who have had bariatric surgery and kidney stones. We leveraged Facebook, Google Search Engine Marketing, and clinical study postings, positioning the study as a potential way to treat kidney stones. We also emphasized the option of remote participation, which would appeal to this patient audience. 

 

Dynamic referral processing was critical, as was collaboration with the CRO, to ensure that all referrals were contacted while interest was high. The effective combination of tactics and messaging resulted in 20 patients enrolled within a four-month period.

  • Sites_ICON 2 Study sites supported in the United States.

  • Calendar_ICON 4 Months of support.

  • Increase-Referrals_ICON-1 300 Referrals generated.

  • Participants_ICON 20 Patients enrolled.

Download the PDF version of this case study today:

Subscribe to stay connected

Share this page:

Familial Amyloid Polyneuropathy — Neurology and Gene Therapy — Phase 3

case-studies-icon Case Studies

October 12, 2021

Pediatric Spinal Muscular Atrophy — Neurology and Rare Disease — Phase 2

case-studies-icon Case Studies

December 13, 2021

Major Depressive Disorder — Mental Health — Pivotal Phase 3 Study

case-studies-icon Case Studies

February 5, 2022

BBK Worldwide, LLC
117 Kendrick St., Suite 600
Needham, MA 02494 United States

        Terms & Conditions  Privacy Policy

        © 2024 BBK Worldwide. BBK Worldwide is a Publicis Health company.

        Facebook LinkedIn YouTube
        Facebook LinkedIn YouTube

        Terms & Conditions  Privacy Policy

        © 2024 BBK Worldwide. BBK Worldwide is a Publicis Health company.